An additional limitation is that the detrimental immune reactivity of CD8+ T cells observed in miscarriage and preeclampsia may be partly due to different timing of sample collection (at 6–8 gestational weeks in miscarriage, and at 32–39 gestational weeks in preeclampsia), albeit this problem cannot be overcome. The gene discussed is CD8A; the disease is Miscarriage.